健民集团: 健民药业集团股份有限公司章程修订对照表

Group 1 - The company has revised its articles of association to clarify the role and responsibilities of the legal representative, stating that the general manager (president) is the legal representative and that the company will appoint a new legal representative within thirty days of resignation [1] - The company has added provisions regarding the legal consequences of civil activities conducted by the legal representative on behalf of the company, stating that the company will bear the legal consequences of such activities [1] - The company has established that shareholders holding more than 3% of shares for over 180 days can request to inspect the company's accounting books and vouchers, with the company having the right to refuse if it believes the request is made for improper purposes [4][5] Group 2 - The company has set a limit on financial assistance provided to individuals for acquiring shares of the company or its parent company, stating that the total amount of such assistance cannot exceed 10% of the issued share capital [2] - The company has clarified that resolutions made by the shareholders' meeting or board of directors that violate laws or regulations can be declared invalid by shareholders [6] - The company has specified that if a resolution is made without proper procedures or if the required number of votes is not met, the resolution can be challenged in court within 60 days [6][7] Group 3 - The company has established that the board of directors must ensure compliance with laws and regulations when making decisions, and that any disputes regarding the validity of resolutions should be promptly brought to court [6][7] - The company has outlined the responsibilities of the audit committee, including the review of financial reports and the hiring of external auditors [27][28] - The company has introduced provisions to protect the rights of minority shareholders, ensuring that independent directors can supervise potential conflicts of interest [32][29]